ZTS

Zoetis

$ 158.42

 Earnings are forecast to grow

 Investors confidence is positive

ZTS Risk Level

ZTS Analysts Opinion

ZTS overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information

ZTS Performance Sentiment

Behind the Scenes of Zoetiss Latest Options Trends. Financial giants have made a conspicuous ish move on Zoetis. Our analysis of options history for Zoetis (NYSE:) revealed 14 unusual trades.Delving into the details we found 57% of traders were ish while 35% showed bearish tendencies. Out of all the trades we spotted 3 were puts with a value of $216721 and 11 were calls valued at $668978.Based on the trading activity it appears that the significant investors are aiming for a price territory stre

Today

Wall Street Analysts Look ish on Zoetis (ZTS): Should You Buy?. The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy sell or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings oft

Today

Zoetis (ZTS) Earnings Expected to Grow: What to Know Ahead of Next Weeks Release. The market expects Zoetis (ZTS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2024. This widely-known consensus outlook is important in assessing the compan

Thu Apr 25, 2024

Zoetis Stock: A Deep Dive Into Analyst Perspectives (5 Ratings). Providing a diverse range of perspectives from ish to bearish 5 analysts have published ratings on Zoetis (NYSE:) in the last three months.The table below provides a snapshot of their recent ratings showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.In the assessment of 12-month price targets analysts unveil insights for Zoetis presenting an average target of $220.0 a high estima

Tue Apr 23, 2024

Understanding Merck &. Cos Position In Pharmaceuticals Industry Compared To Competitors. In today'.s rapidly evolving and fiercely competitive business landscape it is crucial for investors and industry analysts to conduct comprehensive company evaluations. In this article we will undertake an in-depth industry comparison assessing Merck &. Co (NYSE:) alongside its primary competitors in the Pharmaceuticals industry. By meticulously examining crucial financial indicators market positio

Tue Apr 23, 2024

Valideas Top Health Care Stocks Based On Martin Zweig - 4/22/2024. The following are the top rated Health Care stocks according to Valideas Growth Investor model based on the published strategy of Martin Zweig. This strategy looks for growth stocks with persistent accelerating earnings and sales growth reasonable valuations and low debt.ZOETIS

Mon Apr 22, 2024

Zoetis (ZTS) Drops on Report that Arthritis Drugs May Sicken Pets – Hagens Berman. SAN FRANCISCO April 22 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Zoetis Inc. ) and persons with knowledge who may be able to assist the investigation to contact its attorneys.          On Apr. 12 2024 the price of Zoetis shares fell $12.75 or nearly 8% after the WSJ published What Killed Their Pets? Owners Blame Meds but Vets Aren'.t Sure.The WSJ'.s article focuses on Zoetis'. Librela and Solensia

Mon Apr 22, 2024

Exploring The Competitive Space: Eli Lilly and Co Versus Industry Peers In Pharmaceuticals. Amidst today'.s fast-paced and highly competitive business environment it is crucial for investors and industry enthusiasts to conduct comprehensive company evaluations. In this article we will delve into an extensive industry comparison evaluating Eli Lilly and Co (NYSE:) in comparison to its major competitors within the Pharmaceuticals industry. By analyzing critical financial metrics market positio

Fri Apr 19, 2024

ROSEN NATIONAL TRIAL LAWYERS Encourages Zoetis Inc. Investors to Inquire About Securities Class Action Investigation - ZTS. NEW YORK April 18 2024 /PRNewswire/ -- WHY: Rosen Law Firm a global investor rights law firm announces an investigation of potential securities claims on behalf of shareholders of Zoetis Inc. (NYSE: ZTS) resulting from allegations that Zoetis may have issued materially misleading...

Thu Apr 18, 2024

Ex-Dividend Reminder: Zoetis GE HealthCare Technologies and First Busey . Looking at the universe of stocks we cover at Dividend Channel on 4/18/24 Zoetis Inc (Symbol: ZTS) GE HealthCare Technologies Inc (Symbol: GEHC) and First Busey Corp (Symbol: BUSE) will all trade ex-dividend for their respective upcoming dividends. Zoetis Inc will pay its qu

Tue Apr 16, 2024

Despite Lawsuit Risks: Why Zoetis Remains A Compelling Investment.

Sun Apr 14, 2024

ZOETIS ALERT: Bragar Eagel & Squire P.C. is Investigating Zoetis Inc. on Behalf of Zoetis Stockholders and Encourages Investors to Contact the Firm. ) on behalf of Zoetis stockholders. Our investigation concerns whether Zoetis has violated the federal securities laws and/or engaged in other unlawful business practices. to participate in the action.

Sat Apr 13, 2024

Zoetis Inc. Investors: Company Investigated by the Portnoy Law Firm. Investors can contact the law firm at no cost to learn more about recovering their lossesLOS ANGELES April 12 2024 (GLOBE NEWSWIRE) -- ​ advises Zoetis Inc. (Zoetis) (NYSE:) investors that the firm has initiated an investigation into possible securities fraud and may file a class action on behalf of investors. Zoetis investors that lost money on their investment are encouraged to

Fri Apr 12, 2024

Animal Health Giant Zoetis Stock Crumbles: Possible Side Effect Of Its Pet Arthritis Pain Drugs Sickened Dogs Cats. ) tumbled to a 52-week low after a media report suggested the company’.s arthritis shots Librela and Solensia could have sickened dogs and cats.Solensia (frunevetmab)FDA approval in January 2022 for pain associated with osteoarthritis in cats. It became the first monoclonal antibody (mAb) new animal drug approved by the FDA for use in any animal species.In May 2023 the FDA app

Fri Apr 12, 2024

SHAREHOLDER ALERT: Zoetis Investigated by Block & Leviton For Potential Securities Law Violations. Investors Who Have Lost Money Are Encouraged to Contact the Firm. BOSTON April 12 2024 (GLOBE NEWSWIRE) -- Block &. Leviton is investigating Zoetis Inc. (NYSE:) for potential securities law violations. Investors who have lost money in their Zoetis Inc. investment should  to learn more about how they might recover those losses. For more details visit .Shares of Zoetis dropped more than 7% in trad

Fri Apr 12, 2024

Zoetis slips on reports of adverse effects linked to arthritis drugs.

Fri Apr 12, 2024

Zoetis Becomes Oversold. The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks according to a proprietary formula designed to identify those stocks that combine two important characteristics &mdash. strong fundamentals and a valuation that looks inexpensive.

Wed Apr 10, 2024

Assessing Johnson &. Johnsons Performance Against Competitors In Pharmaceuticals Industry. Amidst today'.s fast-paced and highly competitive business environment it is crucial for investors and industry enthusiasts to conduct comprehensive company evaluations. In this article we will delve into an extensive industry comparison evaluating Johnson &. Johnson (NYSE:) in comparison to its major competitors within the Pharmaceuticals industry. By analyzing critical financial metrics market

Tue Apr 9, 2024

This Is What Whales Are Betting On Zoetis. Deep-pocketed investors have adopted a ish approach towards Zoetis (NYSE:) and it'.s something market players shouldn'.t ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown but such a substantial move in ZTS usually suggests something big is about to happen.We gleaned this information from our observations today when Benzinga'.s options scanner highl

Thu Apr 4, 2024

Largest Animal Health Firm Zoetis Hit With European Probe Over Possible Breach of Competition Rules Related To Dog Pain Medicine. The European Commission announced on Tuesday that it hasan investigation into whetherZoetis’. Librela is the first and only monoclonal antibody medicine approved in Europe to treat pain associated with osteoarthritis in dogs.The medicine is administered monthly and offers a novel pain relief option particularly relevant for older dogs.The European Commission said

Wed Mar 27, 2024